SEC Form 4 · accession 0001209191-15-000152

USMD Holdings, Inc. · USMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Dec 31, 2014

Accepted (ET)

Jan 2, 2015 · 2:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001507881

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock ($.01 par)^F1	Dec 31, 2014	J	3,372	$1.02	A	747,284	I	Indirectly held through UANT Ventures, L.P.
Common Stock ($.01 par)^F2	Jan 1, 2015	J	3,859	—	D	743,425	I	Indirectly held through UANT Ventures, L.P.
Common Stock ($.01 par)	holding	—	—		—	13,248	I	Held in John M. House, MD, P.A.
Common Stock ($.01 par)	holding	—	—		—	51,670	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Options to Purchase^F1	$24.84	Dec 31, 2014	J	59	A	Aug 31, 2012	Aug 31, 2017	Common Stock ($.01 par)	59	1,813	I
Options to Purchase^F2	$24.84	Jan 1, 2015	J	68	D	Aug 31, 2012	Aug 31, 2017	Common Stock ($.01 par)	68	1,745	I

F1Dr. House purchased additional partnership interests in UANT Ventures, L.P. ("Ventures"), which resulted in an increase in his indirect beneficial ownership of the shares and options to purchase shares of the issuer's common stock held by Ventures. The aggregate consideration paid by Dr. House for the partnership interest was $3,450, all of which is reflected in the per share price set forth in Column 4 of Table I.
F2Ventures has issued partnership interests to certain individuals and the issuance of these interests was dilutive to the ownership of Ventures held by the existing partners, including Dr. House. This reduction in Dr. House's ownership of Ventures has resulted in a corresponding decrease in his indirect beneficial ownership of shares and options to purchase shares of the issuer's common stock held by Ventures. No consideration was paid and Dr. House did not receive any consideration as a result of the transaction.